176 related articles for article (PubMed ID: 33849755)
1. Hydroa vacciniforme-like lymphoproliferative disorder (HV-LPD) is an Epstein-Barr virus (EBV) associated disease.
Ordoñez-Parra J; Mejía Cortes M; Tamayo-Buendía MM; Infante Gómez AM
An Bras Dermatol; 2021; 96(3):388-390. PubMed ID: 33849755
[No Abstract] [Full Text] [Related]
2. Hydroa Vacciniforme-like Lymphoproliferative disorder in an adult invades the liver and bone marrow with clear pathological evidence: a case report and literature review.
Wang X; Wang P; Wang A; Xu Y; Wang L; Chen Z
BMC Infect Dis; 2021 Jan; 21(1):17. PubMed ID: 33407199
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and disease severity determination criteria for hydroa vacciniforme lymphoproliferative disorders and severe mosquito bite allergy.
Hirai Y; Asada H; Hamada T; Kawada JI; Kimura H; Arai A; Ohshima K; Ohga S; Iwatsuki K;
J Dermatol; 2023 Jul; 50(7):e198-e205. PubMed ID: 37249004
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological categorization of hydroa vacciniforme-like lymphoproliferative disorder: an analysis of prognostic implications and treatment based on 19 cases.
Guo N; Chen Y; Wang Y; Huang Y; Feng Y; Li M; Rao H
Diagn Pathol; 2019 Jul; 14(1):82. PubMed ID: 31315684
[TBL] [Abstract][Full Text] [Related]
5. Hydroa Vacciniforme and Hydroa Vacciniforme-Like Lymphoproliferative Disorder: A Spectrum of Disease Phenotypes Associated with Ultraviolet Irradiation and Chronic Epstein-Barr Virus Infection.
Chen CC; Chang KC; Medeiros LJ; Lee JY
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33297336
[TBL] [Abstract][Full Text] [Related]
6. Hydroa vacciniforme-like lymphoproliferative disorder: A clinicopathological, immunohistochemical, and prognostic study of 24 cases in China.
Wang X; Liang Y; Yang Y; Li W; Wang G; Wang S; Li Y; Zhang M
J Dermatol; 2021 Sep; 48(9):1315-1326. PubMed ID: 33982815
[TBL] [Abstract][Full Text] [Related]
7. Hydroa vacciniforme: a distinctive form of Epstein-Barr virus-associated T-cell lymphoproliferative disorders.
Iwatsuki K; Miyake T; Hirai Y; Yamamoto T
Eur J Dermatol; 2019 Feb; 29(1):21-28. PubMed ID: 30998212
[TBL] [Abstract][Full Text] [Related]
8. Case report: Cellular therapy for hydroa vacciniforme-like lymphoproliferative disorder in pediatric common variable immunodeficiency with chronic active Epstein-Barr virus infection.
Grześk E; Kołtan S; Dąbrowska A; Urbańczyk A; Małdyk J; Małkowski B; Bogiel T; Dębski R; Czyżewski K; Wysocki M; Styczyński J
Front Immunol; 2022; 13():915986. PubMed ID: 35990691
[TBL] [Abstract][Full Text] [Related]
9. [Clinical and pathological features of 13 children with Epstein-Barr virus-positive lymphoproliferative disease].
Chen TM; Deng ZJ; Hu B; Hu HL; Chen HY; Li SY; Liu G
Zhonghua Er Ke Za Zhi; 2018 Oct; 56(10):759-764. PubMed ID: 30293280
[No Abstract] [Full Text] [Related]
10. Hydroa vacciniforme-like Epstein-Barr virus-associated monoclonal T-lymphoproliferative disorder in a child.
Wu YH; Chen HC; Hsiao PF; Tu MI; Lin YC; Wang TY
Int J Dermatol; 2007 Oct; 46(10):1081-6. PubMed ID: 17910721
[TBL] [Abstract][Full Text] [Related]
11. [Delayed diagnosis of hydroa vacciniforme-like lymphoproliferative disorder in a patient with skin rashes].
Umeki Y; Ikeda M; Nakahara W; Asako M; Matsuoka Y; Terakawa T; Matsunaga H; Tadokoro R; Sekiguchi M; Matsui T; Oka K; Higuchi K; Sawada A; Inoue M; Ueda S
Rinsho Ketsueki; 2023; 64(3):209-213. PubMed ID: 37019675
[TBL] [Abstract][Full Text] [Related]
12. Hydroa vacciniforme-like lymphoproliferative disorder: Clinicopathologic study of 41 cases.
Liu Y; Ma C; Wang G; Wang L
J Am Acad Dermatol; 2019 Aug; 81(2):534-540. PubMed ID: 30654082
[TBL] [Abstract][Full Text] [Related]
13. Oral manifestations of Hydroa vacciniforme-like lymphoproliferative disorder: a clinicopathological study of a Peruvian population.
López de Cáceres CVB; Rodrigues-Fernandes CI; Rendón Henao J; Morais TML; Soares CD; de Almeida OP; Fonseca FP; Delgado-Azañero W
J Oral Pathol Med; 2021 Jul; 50(6):530-539. PubMed ID: 34097774
[TBL] [Abstract][Full Text] [Related]
14. Hydroa vacciniforme-like lymphoproliferative disorder in Ecuadorian children: A case series.
Garzón E; Dávila-Rodríguez JJ
Indian J Dermatol Venereol Leprol; 2023; 89(3):403-407. PubMed ID: 33871198
[TBL] [Abstract][Full Text] [Related]
15. Hydroa vacciniforme and hydroa vacciniforme-like T-cell lymphoma: an uncommon event for transformation.
Chen CC; Chang KC; Medeiros LJ; Lee JY
J Cutan Pathol; 2016 Dec; 43(12):1102-1111. PubMed ID: 27531667
[TBL] [Abstract][Full Text] [Related]
16. Atypical hydroa vacciniforme-like epstein-barr virus associated T/NK-cell lymphoproliferative disorder.
Lee HY; Baek JO; Lee JR; Park SH; Jeon IS; Roh JY
Am J Dermatopathol; 2012 Dec; 34(8):e119-24. PubMed ID: 23169419
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus-associated hydroa vacciniforme-like lymphoproliferative syndrome: excellent response to antiviral therapy.
İmren IG; Demirkan N; Çomut E; Duygulu Ş
Int J Dermatol; 2020 Dec; 59(12):e452-e454. PubMed ID: 32808321
[No Abstract] [Full Text] [Related]
18. Hydroa vacciniforme lymphoproliferative disorder: a retrospective study of 42 paediatric cases.
Zhang Y; Liu Y; Xu J; Liang Y; Xu Z
Eur J Dermatol; 2024 Apr; 34(2):144-149. PubMed ID: 38907544
[TBL] [Abstract][Full Text] [Related]
19. Coexpression of natural killer cell antigens by T-cell large granular lymphocytes in hydroa vacciniforme lymphoproliferative disorder and the involvement of Vδ1 + epithelial-type γδT cells.
Hirai Y; Iwatsuki K; Takahashi T; Miyake T; Nakagawa Y; Tanimoto S; Kawakami Y; Morizane S
Int J Hematol; 2023 Jul; 118(1):54-64. PubMed ID: 37133637
[TBL] [Abstract][Full Text] [Related]
20. The association of latent Epstein-Barr virus infection with hydroa vacciniforme.
Iwatsuki K; Xu Z; Takata M; Iguchi M; Ohtsuka M; Akiba H; Mitsuhashi Y; Takenoshita H; Sugiuchi R; Tagami H; Kaneko F
Br J Dermatol; 1999 Apr; 140(4):715-21. PubMed ID: 10233328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
